Rx Green Technologies Raises Strategic Growth Equity Financing From Intrinsic Capital Partners – Leading cultivation inputs and services firm will invest in new manufacturing locations and technology, product research and development, and additional customer resources.
DENVER, Nov. 8, 2021 /PRNewswire/ — Rx Green Technologies (“RXGT”), a leading provider of cannabis cultivation inputs and services, has announced an initial closing of $9.75 million of growth equity financing, its first institutional capital raise. The funding, led by Intrinsic Capital Partners (“Intrinsic”), with significant participation from existing investors, is part of a larger growth financing of up to $11.5 million, which will be used to invest in new manufacturing locations, manufacturing automation technology, new research, and development capabilities and increased customer support. The funding also positions RXGT to capitalize on an active pipeline of acquisition targets with complementary products and competencies.
“We are excited to have the resources to better serve our clients with more locations, upgraded technology, new products, and more services,” said Wes Matelich, CEO of RXGT. “And we’re thrilled to partner with Intrinsic, which has deep industry reach, a strong stable of operating partners, and tremendous experience in scaling life science and technology businesses,” added Matelich.
“At Intrinsic, we’ve spent years studying this industry, have long been interested in the agriculture technology and services sector, and believe Wes and his team have built the industry’s leading platform,” said Intrinsic partner Cornelius Merlini. “Because of its customer-centric direct-to-cultivator relationship model, we believe RXGT is best positioned to support cultivators with the products and services needed to meet growing consumer demand and an increasing emphasis on quality control, compliance, and user safety.”
Based in Colorado and led by experienced agricultural scientists, RXGT’s research and development team has built a sophisticated product development infrastructure focused on formulating cannabis-specific products that are rigorously tested and scientifically backed. All RXGT products are tested by independent labs with strict quality control measures to ensure product safety and, ultimately, help cultivators optimize yield and produce better and safer cannabis products.
“RXGT’s commitment to excellence and safety aligns well with our objective at Intrinsic to partner with exceptional management teams that share our vision of building products, services, and technologies that help ensure supply chain compliance, product integrity, consumer safety, and industry fairness,” added Merlini.
About Rx Green Technologies:
Rx Green Technologies is a cannabis-specific agricultural input company based in Bedford, NH, and Denver, CO. Rx Green Technologies delivers and supports research-backed consumable products to commercial cannabis cultivators, a historically underserved market.
About Intrinsic Capital Partners:
Based in Pennsylvania, Intrinsic Capital Partners is a leading investment firm focused on ancillary life science and technology businesses within the legal cannabis and hemp industries. The Intrinsic team brings institutional investment discipline and world-class operating experience to build and scale industry-leading companies that address unmet needs across the supply chain. Having raised over $100 million for its inaugural growth equity fund, Intrinsic has now made five core platform investments across the cannabinoid landscape, including lab testing (ACT Laboratories), retail management software (Treez), point-of-care breathalyzer technology (Hound Labs), and a hemp-derived consumer healthcare platform (NextEvo Naturals).